Google Play mobile download button
Apple IOS mobile download button
Google Play mobile download button
Apple IOS mobile download button
HomeBusinessRoche gets full FDA approval for COVID-19 treatment

Balanced News: Roche gets full FDA approval for COVID-19 treatment

Our 'quick read' news summary

Roche Holding AG ROG, -1.01% said late Wednesday that the Food and Drug Administration formally approved its monoclonal antibody for adults who have been hospitalized with severe COVID-19. Actemra received an emergency authorization in mid-2021 as a treatment for those 12 years old and older, and more than 1 million people have received treatment with the therapy, which is delivered to patients as one intravenous infusion that takes an hour. Actemra was originally approved to treat rheumatoid arthritis.

Read different perspectives from these news sources

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

More top reads from Balanced News Summary

Do you agree with this post's rating?
0
(0)
- Advertisment -
- Advertisment -